380 related articles for article (PubMed ID: 26142830)
41. Temporal development of behavioral impairments in rats following locus coeruleus lesion induced by 6-hydroxydopamine: Involvement of β
Sampaio TB; Soares de Souza B; Roversi K; Schuh T; Poli A; Takahashi RN; Prediger RD
Neuropharmacology; 2019 Jun; 151():98-111. PubMed ID: 30959019
[TBL] [Abstract][Full Text] [Related]
42. Paradoxical effect of noradrenaline-mediated neurotransmission in the antinociceptive phenomenon that accompanies tonic-clonic seizures: role of locus coeruleus neurons and α(2)- and β-noradrenergic receptors.
Felippotti TT; dos Reis Ferreira CM; de Freitas RL; de Oliveira RC; de Oliveira R; Paschoalin-Maurin T; Coimbra NC
Epilepsy Behav; 2011 Oct; 22(2):165-77. PubMed ID: 21813330
[TBL] [Abstract][Full Text] [Related]
43. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog, (I): Effects on the central nervous system by oral administration.
Yamamura M; Kinoshita K; Nakagawa H; Tanaka T; Maeda K; Ishida R
Jpn J Pharmacol; 1990 Aug; 53(4):451-61. PubMed ID: 2120494
[TBL] [Abstract][Full Text] [Related]
44. Involvement of serotonin 5-HT3 receptors in the modulation of noradrenergic transmission by serotonin reuptake inhibitors: a microdialysis study in rat brain.
Fernández-Pastor B; Ortega JE; Meana JJ
Psychopharmacology (Berl); 2013 Sep; 229(2):331-44. PubMed ID: 23636303
[TBL] [Abstract][Full Text] [Related]
45. Noradrenergic inputs from locus coeruleus to posterior ventral tegmental area are essential to support ethanol reinforcement.
Shelkar GP; Kumar S; Singru PS; Subhedar NK; Kokare DM
Addict Biol; 2017 Mar; 22(2):291-302. PubMed ID: 26549324
[TBL] [Abstract][Full Text] [Related]
46. Stress-induced release of substance P in the locus coeruleus modulates cortical noradrenaline release.
Ebner K; Singewald N
Naunyn Schmiedebergs Arch Pharmacol; 2007 Oct; 376(1-2):73-82. PubMed ID: 17879086
[TBL] [Abstract][Full Text] [Related]
47. Early postnatal development of thyrotropin-releasing hormone (TRH) expression, TRH receptor binding, and TRH responses in neurons of rat brainstem.
Bayliss DA; Viana F; Kanter RK; Szymeczek-Seay CL; Berger AJ; Millhorn DE
J Neurosci; 1994 Feb; 14(2):821-33. PubMed ID: 8301363
[TBL] [Abstract][Full Text] [Related]
48. Expression of thyrotropin-releasing hormone receptor 2 (TRH-R2) in the central nervous system of rats.
Heuer H; Schäfer MK; O'Donnell D; Walker P; Bauer K
J Comp Neurol; 2000 Dec; 428(2):319-36. PubMed ID: 11064370
[TBL] [Abstract][Full Text] [Related]
49. Discrete local application of corticotropin-releasing factor increases locus coeruleus discharge and extracellular norepinephrine in rat hippocampus.
Page ME; Abercrombie ED
Synapse; 1999 Sep; 33(4):304-13. PubMed ID: 10421711
[TBL] [Abstract][Full Text] [Related]
50. β-Arrestin2 Is Critically Involved in the Differential Regulation of Phosphosignaling Pathways by Thyrotropin-Releasing Hormone and Taltirelin.
Drastichova Z; Trubacova R; Novotny J
Cells; 2022 Apr; 11(9):. PubMed ID: 35563779
[TBL] [Abstract][Full Text] [Related]
51. Brain receptor binding characteristics and pharmacokinetics of JTP-2942, a novel thyrotropin-releasing hormone (TRH) analogue.
Urayama A; Yamada S; Deguchi Y; Kimura R; Maeda Y; Kobayashi T
Life Sci; 1999; 65(22):2407-15. PubMed ID: 10597895
[TBL] [Abstract][Full Text] [Related]
52. Antiepileptic potential and behavioral profile of L-pGlu-(2-propyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone analog.
Rajput SK; Krishnamoorthy S; Pawar C; Kaur N; Monga V; Meena CL; Jain R; Sharma SS
Epilepsy Behav; 2009 Jan; 14(1):48-53. PubMed ID: 18952198
[TBL] [Abstract][Full Text] [Related]
53. Localization of amyloid beta peptides to locus coeruleus and medial prefrontal cortex in corticotropin releasing factor overexpressing male and female mice.
Ross JA; Alexis R; Reyes BAS; Risbrough V; Van Bockstaele EJ
Brain Struct Funct; 2019 Sep; 224(7):2385-2405. PubMed ID: 31250157
[TBL] [Abstract][Full Text] [Related]
54. Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex.
Devoto P; Flore G; Longu G; Pira L; Gessa GL
Synapse; 2003 Dec; 50(3):200-5. PubMed ID: 14515337
[TBL] [Abstract][Full Text] [Related]
55. Thyrotropin-releasing hormone in the pancreas and brain of the rat is regulated by central noradrenergic and dopaminergic pathways.
Engler D; Chad D; Jackson IM
J Clin Invest; 1982 Jun; 69(6):1310-20. PubMed ID: 6806317
[TBL] [Abstract][Full Text] [Related]
56. Chronic thyrotropin releasing hormone (TRH) administration on TRH receptors and muscarinic cholinergic receptors in CNS.
Ogawa N; Mizuno S; Nukina I; Tsukamoto S; Mori A
Brain Res; 1983 Mar; 263(2):348-50. PubMed ID: 6301651
[TBL] [Abstract][Full Text] [Related]
57. Effects of chronic risperidone on central noradrenergic transmission.
Nasif FJ; Cuadra GR; Ramirez OA
Eur J Pharmacol; 2000 Apr; 394(1):67-73. PubMed ID: 10771036
[TBL] [Abstract][Full Text] [Related]
58. Calcium-induced calcium release in noradrenergic neurons of the locus coeruleus.
Kawano H; Mitchell SB; Koh JY; Goodman KM; Harata NC
Brain Res; 2020 Feb; 1729():146627. PubMed ID: 31883849
[TBL] [Abstract][Full Text] [Related]
59. Effect of VA-045 on central noradrenergic neuronal system in rats.
Okuyama S; Yamada S; Ogawa S; Kawashima N; Tomisawa K; Shima K; Kamata K
Gen Pharmacol; 1996 Sep; 27(6):1013-7. PubMed ID: 8909984
[TBL] [Abstract][Full Text] [Related]
60. Effect of thyrotropin-releasing hormone on the locomotor and sensitizing effects of cocaine in rats.
Przegaliński E; Papla I; Czepiel K; Wydra K; Nowak E; Lasoń W; Filip M
Neuropeptides; 2004 Feb; 38(1):48-54. PubMed ID: 15003716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
